Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Eris Lifesciences Ltd

NSE: ERIS · BSE: 540596 · Pharmaceuticals & Biotechnology · 41 announcements

Share price
₹1,143.10
Market cap
₹15,859 Cr
Revenue (annual)
₹3,129 Cr
Net profit (annual)
₹619.5 Cr
P/E (TTM)
24.6×Sector 47.4×
Promoter holding
54.14%+0.22% QoQ
FII holding
5.76%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14:39 IST BSE
Financial Results

Eris Lifesciences Q4 FY26 Results: Net Profit ₹279.1 Cr, Up 172.8% YoY

Eris Lifesciences Ltd reported revenue from operations of ₹756.6 Cr (+7.3% YoY) and net profit of ₹279.1 Cr (+172.8% YoY) for Q4 FY26.

Key figure
Net profit ₹279.1 Cr · +172.8% YoY
14:38 IST BSE
Financial Results

Eris Lifesciences Financial Results

Eris Lifesciences reported audited FY26 results and declared an interim dividend of Rs. 7.21 per share. The company recorded consolidated annual net profit of ₹647.51 Crore.

Value
₹7.21 Cr